- 関
- multicenter trial、multicentre study、multicentre trial
WordNet
- be a student; follow a course of study; be enrolled at an institute of learning
- a room used for reading and writing and studying; "he knocked lightly on the closed door of the study"
- applying the mind to learning and understanding a subject (especially by reading); "mastering a second language requires a lot of work"; "no schools offer graduate study in interior design" (同)work
- a composition intended to develop one aspect of the performers technique; "a study in spiccato bowing"
- a state of deep mental absorption; "she is in a deep study"
- someone who memorizes quickly and easily (as the lines for a part in a play); "he is a quick study"
- give careful consideration to; "consider the possibility of moving" (同)consider
- learn by reading books; "He is studying geology in his room"; "I have an exam next week; I must hit the books now" (同)hit the books
- think intently and at length, as for spiritual purposes; "He is meditating in his study" (同)meditate, contemplate
- provide with or construct with studs; "stud the wall"
- ornament consisting of a circular rounded protuberance (as on a vault or shield or belt) (同)rivet
- poker in which each player receives hole cards and the remainder are dealt face up; bets are placed after each card is dealt (同)stud poker
- adult male horse kept for breeding (同)studhorse
- a man who is virile and sexually active (同)he-man, macho-man
PrepTutorEJDIC
- 〈U〉(一般に)『勉強』,学習すること / 〈C〉(…の)勉強,研究《+of+名》 / 〈C〉〈U〉(…の)『綿密な調査』,検討《+of+名》 / 〈C〉研究対象(問題,事項);学科 / 〈C〉『書斎』,勉強部屋 / 〈C〉(美術・文学などの)習作,試作,スケッチ,(音楽の)練習曲,エチュード / …‘を'『勉強する』,学ぶ,研究する / …‘を'『よく注意して見る』,しげしげと見る / …‘を'『調査する』,検討する / …‘を'考慮する,配慮する / 〈せりふなど〉‘を'覚えようとする / 『勉強する』,学ぶ,研究する
- 《おもに米》種馬 / 《集合的に》(一群の)繁殖用動物(種馬,種牛など)
- (インテリアなどに用いる)飾りびょう / カフスボタン,カラーボタン / (建物の)間柱 / (…を)…‘に'ちりばめる《+名+with+名》 / …‘に'点在(散在)している / …‘に'間柱をつける
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial.
- Sanyal A, Charles ED, Neuschwander-Tetri BA, Loomba R, Harrison SA, Abdelmalek MF, Lawitz EJ, Halegoua-DeMarzio D, Kundu S, Noviello S, Luo Y, Christian R.
- Lancet (London, England). 2019 12;392(10165)2705-2717.
- Pegbelfermin (BMS-986036), a PEGylated human fibroblast growth factor 21 (FGF21) analogue, has previously been shown to improve markers of metabolism and liver fibrosis in obese patients with type 2 diabetes. In this phase 2a study, we aimed to evaluate the safety and efficacy of pegbelfermin in pat
- PMID 30554783
- Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial.
- Reisinger EC, Tschismarov R, Beubler E, Wiedermann U, Firbas C, Loebermann M, Pfeiffer A, Muellner M, Tauber E, Ramsauer K.
- Lancet (London, England). 2019 12;392(10165)2718-2727.
- Chikungunya fever is an emerging viral disease and substantial threat to public health. We aimed to assess the safety, tolerability, and immunogenicity of a live-attenuated, measles-vectored chikungunya vaccine (MV-CHIK). In this double-blind, randomised, placebo-controlled and active-controlled pha
- PMID 30409443
- Minimal residual disease level predicts outcome in adults with Ph-negative B-precursor acute lymphoblastic leukemia.
- Gökbuget N, Dombret H, Giebel S, Bruggemann M, Doubek M, Foà R, Hoelzer D, Kim C, Martinelli G, Parovichnikova E, Rambaldi A, Ribera JM, Schoonen M, Stieglmaier JM, Zugmaier G, Bassan R.
- Hematology (Amsterdam, Netherlands). 2019 Dec;24(1)337-348.
- Detectable minimal residual disease (MRD) after therapy for acute lymphoblastic leukemia (ALL) is the strongest predictor of hematologic relapse. This study evaluated outcomes of patients with B-cell precursor ALL with MRD of ≥10 Methods: Study population was from ALL study groups in Europe manage
- PMID 30757960
Japanese Journal
- Variations in infection sites and mortality rates among patients in intensive care units with severe sepsis and septic shock in Japan
- Abe Toshikazu,Ogura Hiroshi,Kushimoto Shigeki,Shiraishi Atsushi,Sugiyama Takehiro,Deshpande Gautam A.,Uchida Masatoshi,Nagata Isao,Saitoh Daizoh,Fujishima Seitaro,Mayumi Toshihiko,Hifumi Toru,Shiino Yasukazu,Nakada Taka-aki,Tarui Takehiko,Otomo Yasuhiro,Okamoto Kohji,Umemura Yutaka,Kotani Joji,Sakamoto Yuichiro,Sasaki Junichi,Shiraishi Shin-ichiro,Takuma Kiyotsugu,Tsuruta Ryosuke,Hagiwara Akiyoshi,Yamakawa Kazuma,Masuno Tomohiko,Takeyama Naoshi,Yamashita Norio,Ikeda Hiroto,Ueyama Masashi,Fujimi Satoshi,Gando Satoshi,JAAM FORECAST group
- Journal of Intensive Care (7), 28, 2019-05-03
- … Methods This secondary analysis of a multicenter, prospective cohort study included 59 intensive care units (ICU) and proceeded between January 2016 and March 2017. … The study cohort comprised 1184 adults (≥ 16 years) who were admitted to an ICU with severe sepsis and septic shock diagnosed according to the sepsis-2 criteria. …
- NAID 120006631021
- Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: a multicenter case-control study of 240 patients
- Aoki Shuichi,Motoi Fuyuhiko,Murakami Yoshiaki,Sho Masayuki,Satoi Sohei,Honda Goro,Uemura Kenichiro,Okada Ken-ichi,Matsumoto Ippei,Nagai Minako,Yanagimoto Hiroaki,Kurata Masanao,Fukumoto Takumi,Mizuma Masamichi,Yamaue Hiroki,Unno Michiaki
- BMC Cancer (19), 252, 2019-03-21
- … This study aimed to define the prognostic significance of decreased CA19–9 levels after neoadjuvant therapy in patients with pancreatic adenocarcinoma. …
- NAID 120006604677
- Aldose reductase inhibitor ranirestat significantly improves nerve conduction velocity in diabetic polyneuropathy: A randomized double-blind placebo-controlled study in Japan
- Sekiguchi Kenji,Kohara Nobuo,Baba Masayuki,Komori Tetsuo,Naito Yutaka,Imai Tomihiro,Satoh Jo,Yamaguchi Yasuyuki,Hamatani Tatsuto,the Ranirestat Group
- Journal of Diabetes Investigation 10(2), 466-474, 2019-03
- … Materials and Methods This was a multicenter, placebo-controlled, randomized double-blind, parallel-group, phase III study in which 557 patients were randomly assigned to either the ranirestat or placebo group and assessed for 52 weeks. …
- NAID 120006599161
Related Links
- Study 221 was a multicenter, open-label trial conducted in advanced or recurrent breast cancer patients previously treated with an anthracycline and a taxane. eisai.com 2 2 1試験は 、ア ントラサイクリン及びタキサン系抗がん剤による前治療歴のある進行・再発乳がんの患者様を対象とした、多施 設共同による非盲検の試験です。
- An early sustained increase in serum creatinine is a known risk factor for graft loss in kidney transplant patients. Olerup XM-ONE® positive patients in the multicenter study had significantly higher levels of serum creatinine at 3 (p
- Use of a digital phantom developed by QIBA for harmonizing SUVs obtained from the state-of-the-art SPECT/CT systems a multicenter study Tadaki Nakahara, Hiromitsu Daisaki, Yasushi Yamamoto, Takashi Iimori, Kazuyuki ...
★リンクテーブル★
[★]
- 英
- multicenter trial、multicenter study、multicentre trial、multicentre study
[★]
- 関
- multicenter study、multicentre study、multicentre trial
[★]
多施設治験
- 関
- multicenter study、multicenter trial、multicentre trial
[★]
多施設治験
- 関
- multicenter study、multicenter trial、multicentre study
[★]
- 研究、勉学、学習
- (～の)研究、学問。[-ies](従事している)研究、学業(in,on,of,into)
- 慎重な調査、詳細な検討
- 研究対象/研究題目。研究論文、論考。[-ies]学科
- (～に関して)研究に値するもの、見もの、(～の)具体例(in)
- 書斎、勉強部屋、研究室
- 関
- examine、exploration、explore、inquire、inquiry、investigate、investigation、investigational、investigative、laboratory research、probing、research、scan、surveillance、survey、work
[★]
- 関
- multicentre、multicentric、multicentricity
[★]